Core Scientific Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio7.68
P/B Ratio-4.78
Price/OCF91.47
Enterprise Value Ratios
EV/Revenue8.30
EV/EBITDA43.15
Profitability & Returns
Return on Equity (ROE)-4.40%0.06%-0.09%
Return on Assets (ROA)-0.01%0.01%-0.17%0.06%-0.04%
Return on Invested Capital (ROIC)0.03%-0.33%0.09%-0.08%
Return on Capital Employed (ROCE)-0.01%0.07%-0.80%0.06%-0.08%
Leverage & Solvency Ratios
Debt/Equity-1.46-1.52-2.390.590.30
Debt/EBITDA10.628.414.89
Debt/FCF18.55
Liquidity Ratios
Current Ratio6.720.180.312.361.02
Quick Ratio6.220.090.060.370.14
Efficiency Ratios
Asset Turnover0.440.660.390.410.31
Yield & Distribution Ratios
Earnings Yield-0.34%
FCF Yield-0.01%
Buyback Yield0.33%-0.12%-0.46%-0.48%-0.60%